Rel/NF-kB transcription factors are primarily regulated by association with inhibitor IkB proteins. Thus, in most cells NF-kB exists in the cytoplasm in an inactive complex bound to IkB. Most agents that activate NF-kB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IkB. The key regulatory step in this pathway involves activation of a high molecular weight IkB kinase (IKK) complex, whose catalysis is generally carried out by a heterodimeric kinase consisting of IKKa and IKKb subunits. This review describes the identi®cation of proteins in the IKK complex, and the regulation and physiological functions of IKK.
Introduction
As described elsewhere in this issue, Rel/NF-kB proteins are dimeric, DNA sequence-speci®c transcription factors that control many important biological decisions, from formation of dorsal-ventral polarity in insects to activation of in¯ammatory and innate immune responses (reviewed in Baeuerle and Baltimore, 1996) . The NF-kB proteins (p50/p105, p52/p100, p65/RelA, RelB, c-Rel, Dosal, Dif, and Relish) share a Rel homology (RH) domain, which subjects them to a particular type of regulation ± centered around nuclearcytoplasmic shuttling (reviewed in . The RH domain, composed of two immunoglobulin-like repeats, serves several functions: it is the dimerization and DNA-binding domain for this class of proteins, it contains the nuclear localization sequence (NLS), and most important for its regulation it is the site for binding of the NF-kB inhibitors, the IkBs (reviewed in Chen and Ghosh, 1999, this issue) .
The IkBs form a small family of related proteins with a core consisting of six or more ankyrin repeats, an N-terminal regulatory domain and a C-terminal domain that contains a PEST motif (Figure 1 ). The best-studied and major IkB protein is IkBa. The IkBs bind to NF-kB dimers and sterically block the function of their NLSs, thereby causing their cytoplasmic retention. In order to get NF-kB into the nucleus, its site of action, the cytoplasmic NF-kB:IkB complex needs to be disrupted. As it turns out, most agents that induce NF-kB activation, including tumor necrosis factor a (TNFa), interleukin 1 (IL-1), bacterial lipopolysaccharide (LPS), viral double stranded (ds) RNA and ionizing radiation, all achieve complex disruption via a common pathway based on the phosphorylation-induced degradation of IkBs. Certain IkBs, such as IkBa, contain both an NLS and a nuclear export sequence (NES) such that the signal can be abrogated by newly-synthesized IkBa entering the nucleus, removing NF-kB dimers from DNA, and causing their exportin-mediated transport to the cytoplasm (Arenzana-Seisdedos et al., 1997; Sachdev et al., 1998) .
The activation pathway for Rel/NF-kB proteins is also used to activate the NF-kB homologs in Drosophila (Homann et al., 1999; Reach et al., 1996) . Therefore, it is an evolutionarily-conserved regulatory pathway that appeared rather early during evolution of the animal kingdom. This pathway is used both to activate innate immune responses to various pathogens (Homann et al., 1999) and to control developmental decisions (Belvin and Anderson, 1996) .
Regulation of IkB turnover
Although NF-kB was initially thought to be a B cellspeci®c transcription factor (Baeuerle and Baltimore, 1996) , it was quickly recognized that its activity can be induced in most cell types upon treatment with phorbol esters, the proin¯ammatory cytokines TNFa and IL-1, or bacterial LPS. Subsequently, the list of ecient NFkB inducers grew to contain dsRNA, certain viruses, the Tax transactivator of HTLV-1, and ionizing radiation (Pahl, 1999, this issue) . It was also recognized that upon cell stimulation with these inducers, NF-kB dimers translocate from the cytoplasm to the nucleus where they bind target genes and regulate their transcription. Subsequently, the nuclear translocation of NF-kB was found to parallel and depend on induction of IkB degradation (reviewed in Verma et al., 1995) .
Potent NF-kB activators, such as TNFa and IL-1, cause almost complete degradation of IkBs (especially IkBa) within minutes. This process, which is mediated by the 26S proteasome (Alkalay et al., 1995; DiDonato et al., 1995) , depends on phosphorylation of two conserved serines (S32 and S36 in human IkBa) in the N-terminal regulatory domain of IkBs (Brown et al., 1995; Chen et al., 1995; DiDonato et al., 1996) . Homologous serines are also required for degradation of the Drosophila IkB homolog, Cactus (Reach et al., 1996) . Substitutions that replace even a single serine are sucient for considerable inhibition of IkB degradation. In fact, the regulatory serines cannot even be replaced by threonines, indicating that the kinase that phosphorylates the N-terminal sites of IkB is serine-speci®c (DiDonato et al., 1996) . If proteasomal function is inhibited, the N-terminally phosphorylated form of IkBa rapidly accumulates, indicating that phosphorylation of IkB precedes its degradation and does not disrupt the NF-kB:IkB complex (Alkalay et al., 1995; DiDonato et al., 1995) . Once phosphorylated, the IkBs, still bound to NF-kB, almost immediately undergo a second post-translational modi®cation ± polyubiquitination. The major ubiquitin acceptor sites in human IkBa are lysines 21 and 22, whose substitution with arginines considerably retards IkBa degradation (DiDonato et al., 1996; Scherer et al., 1995) .
Protein polyubiquitination occurs through a cascade of enzymatic reactions, the ®rst of which is ATPdependent and is carried out by the E1 ubiquitinactivating enzyme, which forms an E1-ubiquitin thioester. The second reaction is catalyzed by E2 ubiquitin conjugating enzymes, which receive activated ubiquitin from E1. While there is only a single E1, there are numerous E2s, each responsible for modification of a distinct set of substrates. The last step in the ubiquitination cascade, the transfer of activated ubiquitin from the E2-ubiquitin intermediate to the substrate, is catalyzed by the E3 ubiquitin-protein ligases (Hershko and Ciechanover, 1998) . The E3 group is even larger than the E2 group, is very heterogeneous and most of its members are poorly characterized.
Recently, a cell-free system that catalyzes the ubiquitination of N-terminally phosphorylated IkBa was established and used to demonstrate that the only regulated step in the IkB degradation pathway is the IkB phosphorylation reaction (Yaron et al., 1997) . By contrast, the ubiquitinating activity that speci®cally recognizes N terminally-phosphorylated IkBs is constitutive. Yaron et al. (1998) employed this elegant cellfree system along with highly sensitive protein puri®cation and sequence determination technology to molecularly identify the component of the E3 activity responsible for recognition of phospho-IkB. This protein, named E3RS IkB , turned out to be a member of the F-box/WD-repeat family (reviewed in Patton et al., 1998) . Interestingly, other members of this family, which contain an F-box and one or two WD or leucine-rich repeats, are essential components of E3 activities involved in regulated protein degradation (Bai et al., 1996; Feldman et al., 1997; Skowyra et al., 1997) . For instance, two members of this group, Cdc4 and Grr1, that share 30% similarity with E3RS IkB , mediate the binding of their cognate E3 complexes to phosphorylated substrates, Sic1 and Cln2, respectively. E3RS
IkB , Cdc4 and Grr1, recognize phosphoamino acids that are embedded within a speci®c sequence through their WD repeat domain (Patton et al., 1998; Yaron et al., 1998) . The F box domain, on the other hand, is responsible for binding to Skp1, which in turn binds to members of the Cullin family, such as Cdc53 or Cul1 (Feldman et al., 1997; Skowyra et al., 1997) . The Cullin subunit appears to mediate recruitment of E2-ubiquitin onto the phosphorylated substrate (Patton et al., 1998) . E3RS IkB is essentially identical to b-TrCP, which was previously isolated via a two-hybrid screen as a protein that binds to the phosphorylated version of the human immunode®ciency virus type 1 protein Vpu (Margottin et al., 1998) . Phospho-Vpu binds CD4, a T-cell membrane protein, to induce its ubiquitination and degradation. Curiously, Vpu contains a sequence very similar to the one surrounding the phospho-acceptor sites of IkBs. This sequence, DS P GCXS P , is also present in b-catenin, another protein whose abundance is regulated through ubiquitin-dependent degradation (Aberle et al., 1997) . Genetic analysis has indeed shown that degradation of the Drosophila b-catenin homolog Armadillo depends on a homolog of E3RS IkB called Slimb (Jiang and Struhl, 1998) . Therefore, rather than serving as a recognition sequence for the IkB kinase, as originally expected, the conserved sequence surrounding the IkB N-terminal phosphoacceptor sites is a recognition site for E3RS IkB , whose binding to IkB is strictly dependent on the phosphorylation of the two serines (Yaron et al., 1998) . Indeed, the sequence similarity between the IkB and b-catenin phosphorylation sites led other investigators to examine and con®rm the involvement of the mammalian Slimb homolog, b-TrCP, in IkB ubiquitination and degradation (Winston et al., 1999) . Using coimmunoprecipitation experiments it was found that like other F box proteins, E3RS
IkB also associates with Skp1 and Cul1 (Winston et al., 1999) . At this point, however, the particular E2 that works in conjunction with E3
IkB to catalyze IkB ubiquitination needs to be identi®ed.
IkB kinase and its regulation
The enzymes that catalyze the ubiquitination of phospho-IkB are constitutively active. Hence, the only regulated step that dictates the fate of IkB and NF-kB Figure 1 Vertebrate IkB proteins. The generalized structures of the most common vertebrate IkB proteins are shown. All have multiple ankyrin repeats (dark boxes), which are required for interaction with RH domains. p105 and p100 are the long forms of p50 and p52, respectively, and they can act as IkB proteins by virtue of their C-terminal ankyrin repeat domains. IkBg corresponds to the C-terminal domain of p105 and is encoded by an mRNA initiated from an internal nfkb1 promoter. IkBa, IkBb and IkBe have an N-terminal regulatory domain, which contains sites of signal-induced serine phosphorylation (SS) and phosphorylation-dependent ubiquitination, and a C-terminal PEST domain, which is involved in constitutive turnover. Bcl-3 is a member of this family, in that it can associate with p50 and p52 homodimers to activate transcription through its N-terminal proline-rich and C-terminal serine/proline-rich sequences is in most cases the phosphorylation of the two Nterminal serines in the IkB molecule. As the E3 IkB complex may also be involved in degradation of CD4 and b-catenin, the phosphorylation step is also the one that provides speci®city to this signaling pathway. There are only two exceptions to this universal pathway for NF-kB activation. The ®rst is activation of NF-kB in response to UV radiation, which although dependent on IkB degradation does not involve Nterminal IkB phosphorylation (Bender et al., 1998; Li and Karin, 1998) . The second exception is anoxia, which stimulates phosphorylation of IkBa at tyrosine 42 (Imbert et al., 1996) . The tyrosine phosphorylated IkBa has been suggested to bind to the SH2 domain of PI3 kinase, which pulls it away from NF-kB (Beraud et al., 1999) . This tyrosine residue at position 42 of IkBa, however, is not conserved in other IkB proteins and therefore the universality of this pathway is questionable. The control of IkB phosphorylation in response to all other NF-kB activating stimuli rests on the shoulders of the IkB kinase (IKK) complex.
Once it became clear that the key event in NF-kB activation was IkB phosphorylation, the next logical step was to search for a stimulus-responsive IkB kinase (IKK) that could catalyze this event. This eort bore fruit three years ago when a protein kinase that speci®cally phosphorylates the N-terminal regulatory serines of IkBs and whose activity was greatly stimulated by TNFa was identi®ed (DiDonato et al., 1997; Mercurio et al., 1997) . This IKK activity was shown to be serine-speci®c and responsive to a number of potent NF-kB activators in addition to TNFa, which stimulate its activity with kinetics that match those of IkBa degradation (DiDonato et al., 1997) . The extent to which IKK is activated by a given stimulus seems to dictate the kinetics of IkB degradation. Gel ®ltration experiments suggested that IKK is a protein complex and indeed, protein puri®cation, microsequencing and molecular cloning have so far resulted in identi®cation of three tightly-associated IKK polypeptides. Two of these polypeptides, IKKa (also called IKK1) and IKKb (IKK2) serve as the catalytic subunits of the kinase (DiDonato et al., 1997; Mercurio et al., 1997; Zandi et al., 1997 Zandi et al., , 1998 , whereas the third polypeptide, IKKg (also known as NEMO or IKKAP1), serves as its regulatory subunit (Mercurio et al., 1999; Rothwarf et al., 1998; Yamaoka et al., 1998) .
IKKa was also isolated through a two-hybrid screen as a protein that interacts with the MAP kinase kinase kinase (MAP3K), NIK (NF-kB inducing kinase) (ReÂ gnier et al., 1997) . Although in overexpression experiments in tissue culture cells NIK acts as a potent activator of both IKK and NF-kB (Karin and Delhase, 1998; Malinin et al., 1997; ReÂ gnier et al., 1997; Woronicz et al., 1997) , recent experiments question its involvement in IKK activation by either TNFa or IL-1 . In support of these results based on transient transfection experiments, it was recently found that the aly mutation of the mouse, which results in loss of lymphoid organs, is a point mutation in the gene encoding NIK (Shinkura et al., 1999) . Analysis of cells derived from aly mice indicates that IL-1 and TNFa-mediated activation of NF-kB are normal. As the phenotypic appearance of aly mice is similar to that of lymphotoxin (LT)-de®cient mice (Shinkura et al., 1999) , it is likely that NIK functions as a mediator of LT signaling and has no role in TNFa or IL-1 signaling. Although an interaction between NIK and IKKa was detected in yeast cells or upon overexpression of the two kinases in mammalian cells, so far it has not been detected under physiological conditions. In addition the IKKa subunit, which was proposed to be the preferential target for NIK (Ling et al., 1998) , is not directly involved in IKK activation Hu et al., 1999) .
IKKa and IKKb have very similar primary structures (52% overall identity) and contain protein kinase domains at their N termini, and leucine zippers (LZ) and helix ± loop ± helix (HLH) motifs in their Cterminal portions (Figure 2 ). IKKg does not contain a recognizable catalytic domain but is composed mostly of three large a-helical regions, including a LZ ( Figure  2 ). Biochemical analysis of two human cell lines indicates that the predominant form of IKK is an IKKa:IKKb heterodimer associated with either a dimer or trimer of IKKg (Rothwarf et al., 1998) . A fourth protein, an IKK complex-associated protein called IKAP, has been proposed to be involved in IKK activation (Cohen et al., 1998) . However, as IKAP is not a readily detected constituent of the IKK complex, its physiological signi®cance and function are not yet clear. Furthermore, sequence analysis suggests that IKAP is the human homolog of one of the components of the yeast transcriptional elongation`Elongator' complex (Otero et al., 1999) . Thus, IKAP is most probably a nuclear protein and, thus, is unlikely to serve as a component of the cytoplasmic IKK complex.
As mentioned above, native IKK complexes puri®ed from mammalian cells so far seem to be assembled only from IKKa:IKKb heterodimers plus an undetermined number of IKKg subunits (Rothwarf et al., 1998) . In vitro, IKKa and IKKb can form both homoand heterodimers in a manner that depends on integrity of their LZ motifs . It is therefore possible that IKKa:IKKb heterodimers form ®rst and then interact with IKKg, which mediates formation of a dimer of dimers. Indeed, in IKKgde®cient cells, IKKa and IKKb are present in a 300 kDa complex as opposed to the large 700 ± 900 kDa complex present in wild-type cells (Yamaoka et al., 1998) . The small 300 kDa complex is also detected when either IKKa or IKKb are overexpressed and crosslinking indicates that this complex is a dimer of IKKa and IKKb .
When examined as transiently expressed epitopetagged proteins in mammalian cells, IKKa and IKKb exhibit identical activation kinetics and substrate speci®cities Zandi et al., 1997) . However, it is important to realize that although highly reproducible, such experiments are somewhat misleading because the transiently expressed proteins readily interchange with their endogenous counterparts and are incorporated into the large IKK complex . Thus, when epitope-tagged IKKa is precipitated and its associated IkB kinase activity is measured, it is not clear whether one is measuring the activity of the exogenous IKKa protein or the activities of endogenous IKKa or IKKb with which it associates. Even catalytically inactive mutants of IKKa and IKKb have been found to associate with a substantial amount of cytokine inducible IkB kinase activity upon transient expression . Nevertheless, vast overexpression of catalytically inactive IKKa or IKKb can inhibit NF-kB activation in response to TNFa, as measured by inhibition of nuclear translocation of RelA .
The kinase activities of IKKa and IKKb and their abilities to be activated depend on their LZ-mediated dimerization, and LZ mutations that interfere with this process abolish IkB kinase activity . IKKa or IKKb activity is also abolished by mutations within the HLH motif . The HLH mutations, however, do not interfere with dimerization or binding to IKKg. Rather, the HLH motif appears to interact with the kinase domain and can stimulate its activity when expressed in trans .
IKK activation is also dependent on the presence of an intact IKKg subunit. Neither IKK nor NF-kB activity can be elicited in IKKg-de®cient cells after treatment with TNFa, IL-1, endotoxin or dsRNA (Yamaoka et al., 1998) . In addition, IKK complexes assembled on a truncation mutant of IKKg that lacks its C-terminal LZ are refractory to all of these agonists (Rothwarf et al., 1998) . These results provide a genetic proof for the importance of IKK in NF-kB activation and suggest that the C-terminal region of IKKg is necessary for recruitment of upstream activators (presumably IKK-kinases or IKK-Ks). In addition, overexpression of IKKg can inhibit IKK activation due to titration of limiting IKK activators that remain to be identi®ed (Li et al., 1999b) .
Activation of IKK depends on phosphorylation of its IKKb subunit . The ®rst evidence of a role for phosphorylation in IKK activation was obtained by treatment of puri®ed, activated IKK complex with protein phosphatase 2A (PP2A), which resulted in IKK inactivation (DiDonato et al., 1997). In addition, treatment of cells with okadaic acid, a PP2A inhibitor, results in slow activation of IKK (and consequently NF-kB). More recently, incubation of cells with TNFa was shown to stimulate the phosphorylation of all three IKK subunits . IKKa and IKKb are phosphorylated exclusively at serines, whereas IKKg is phosphorylated on serine and threonine. The location of these serines has been biochemically mapped only for IKKb, but it can be assumed that the equivalent sites are also phosphorylated on IKKa. Two of the IKKb phospho-acceptor serines are located in its activation loop , a portion of the kinase domain that is similar to a region involved in the phosphorylation-dependent activation of other protein kinases (Zheng and Guan, 1994) . Most frequently, the non-phosphorylated form of the activation loop folds back onto the kinase domain and interferes with entry of ATP and peptide substrates into the catalytic pocket. Phosphorylation moves the activation loop away from the catalytic pocket, thus allowing the entry and binding of substrates (Johnson et al., 1996) . Replacement of the two phospho-accepting serines (S177 and S181) in the T loop of IKKb with alanines prevents its activation, while their replacement with phospho-mimetic glutamate residues causes constitutive activation Mercurio et al., 1997) . Interestingly, however, replacement of the equivalent serines (S176 and S180) in IKKa abolishes IKKa autophosphorylation but has no eect on the stimulation of total IKK activity associated with the IKKa(A176/A180) mutant by TNFa, IL-1 or the upstream kinases MEKK1 and NIK . These results were the ®rst to point out functional dierences between the two catalytic subunits, and these results were later con®rmed by genetic analysis. Based on these results, IKK is activated in response to proin¯ammatory stimuli through phosphorylation of IKKb; although IKKa phosphorylation is concurrent with that of IKKb, it is not essential for stimulation of IkB kinase activity. In other words, the IKKb subunit and not IKKa serves as the target for upstream activators involved in proin¯ammatory signaling. These activators are recruited to the complex via the IKKg subunit, most likely through interaction with its C-terminal domain.
Phosphorylation can also result in negative regulation of IKK activity. In addition to its activation loop, IKKb is extensively phosphorylated within a region located between its HLH motif and the C terminus, which contains multiple serines . Phosphorylation of these serines depends on autokinase activity and presumably occurs subsequent to phosphorylation of the activation loop. Mutagenesis experiments indicate that the C-terminal autophosphorylation sites are involved in downregulation of kinase activity . Replacement of nine or ten of the C-terminal serines of IKKb with alanines results in a mutant that remains active four times longer than the wild-type enzyme, while substitution of the same sites with phosphomimetic glutamic acid residues results in a mutant enzyme that can hardly be activated. Based on these results, a threestep model was proposed to explain the regulation of IKK activity (Figure 3; Delhase et al., 1999) . Initially, the inactive IKK complex is not phosphorylated. In response to upstream stimuli IKK-Ks are activated and recruited to the IKK complex via the IKKg subunit. This results in phosphorylation of the IKKb activation loop and activation of IKK. It is likely that only a small fraction of IKK is initially activated through direct phosphorylation by IKK-Ks. However, through trans-autophosphorylation the activated IKKb subunit can phosphorylate an adjacent subunit, which can be either IKKa or IKKb as well as other inactive IKK complexes through an intermolecular reaction. In support of this assumption, the mere overexpression of IKKb in Sf9 insect cells is sucient for its activation, and this activation is absolutely dependent on its autophosphorylation. The activated IKK complexes then phosphorylate IkB subunits in NFkB:IkB complexes, triggering their ubiquitin-dependent degradation, and the activation of NF-kB. Concurrently and maybe due to the decrease in IkB abundance, the activated IKKb subunits (and presumably the IKKa subunits as well) undergo Cterminal autophosphorylation. This reaction, which is unlikely to be processive, but could be regulated by the level of IkB, operates as a timing device such that when at least nine of the C-terminal serines are phosphorylated the enzyme reaches a low activity state. Once at this state, IKK becomes sensitive to inactivation by phosphatases, especially once the upstream signal has disappeared. As the C-terminal autophosphorylation sites are adjacent to the HLH motif they may exert their negative eect on kinase activity by changing the conformation of this intrinsic kinase activator domain and aecting its interaction with the catalytic domain. This mode of regulation explains why IKK is usually activated in a highly transient fashion.
Due to the ability of IKKb to propagate its active state via autophosphorylation it is important to have a mechanism for decreasing its kinase activity and render it sensitive to inactivation by a phosphatase. Without negative autoregulation, a single bolus of a proinammatory cytokine could result in prolonged IKK activation leading to prolonged NF-kB activation followed by increased production of both primary and secondary in¯ammatory mediators. As these mediators can cause further NF-kB activation (Barnes and Karin, 1997) , there is a genuine risk that in the absence of ecient negative feedback mechanisms even a minor proin¯ammatory insult would result in a major catastrophe, such as septic shock.
Interestingly, however, constitutive IKK activation can occur in pathogenic states and was recently documented in Hodgkin's disease cells (Krappmann et al., 1999; reviewed in Rayet and GeÂ linas, 1999, this issue) and in HTLV-1-infected T cells (Uhlik et al., 1998; reviewed in Sun and Ballard, 1999, this issue) . Although the molecular bases for these alterations in IKK behavior are unknown, the constitutive NF-kB activation which ensues protects these cells from induction of apoptosis by radio-and chemo-therapy (Bargou et al., 1997). In fact, elevated NF-kB and IKK activity may protect numerous types of tumors from apoptosis-inducing therapies (Gilmore, 1997) . Thus, IKK is an attractive target for the development of new anti-tumor drugs. However, as shall be discussed below, the complete inhibition of IKK activity is likely to result in undesirable side-eects.
IKK function
The presence of two closely-related, yet distinct, catalytic subunits within the IKK complex is certainly not a common occurrence among protein kinases, and it therefore raises a few questions. Are the biochemical and physiological activities of IKKa and IKKb Figure 3 A three-step model for regulation of IKK activity by phosphorylation. The two catalytic subunits of IKK (IKKa and IKKb) associate into a heterodimer via their leucine zippers (LZ). In non-stimulated cells, the activation loop within the kinase domain (KD) is not phosphorylated, and the helix ± loop ± helix (HLH) motif contacts the kinase domain. The C-terminal phosphorylation cluster is not phosphorylated either. Upon cell stimulation with TNFa or IL-1, the activation loop of IKKb is phosphorylated and through trans-autophosphorylation of the second subunit (either IKKa or IKKb, in the case of a homodimer) IKK is activated. Once activated, in addition to phosphorylation of IkBs, IKK undergoes progressive autophosphorylation at its C-terminal serine cluster. When at least nine of the C-terminal serines are phosphorylated, electrostatic repulsion alters the interaction between the activating HLH motif and the kinase domain such that the kinase reaches a low activity state. In this state IKK is likely to be more prone to inhibition by phosphatase action completely redundant? Alternatively, is each subunit responsible for the phosphorylation of dierent substrates and even subject to dierential regulation? Initially, little dierence between IKKa and IKKb was observed and it was assumed that the two have identical functions. However, the analysis of the IKKa and IKKb phosphorylation site mutants discussed above indicated that IKKb and not IKKa is the target for proin¯ammatory stimuli . These results have now been extended and con®rmed by the genetic analysis of IKKa and IKKb function through the use of gene targeting technology.
The ®rst surprise produced by these experiments was the phenotype of IKKa-de®cient mice. The absence of IKKa results in perinatal lethality within 30 ± 60 min of birth (Hu et al., 1999; Takeda et al., 1999) . Newborn ikka 7/7 mice exhibit rudimentary limbs and tail, a large omphalocele, and severe craniofacial deformity, but most striking is their skin which is taut, shiny and smooth. However, as usual, ®rst impressions are misleading and the ikka 7/7 mice were found to contain limb bones of almost normal size, but they are hidden under their thickened skin (Hu et al., 1999; Takeda et al., 1999) . While the proximal limb bones are normal in appearance and ossi®cation, some of the distal elements, such as the phalanxes, are missing and others are fused. Other notable skeletal abnormalities include a partially split sternum, fused vertebrae and severe truncation of the skull. Yet, the most dramatic change is in the organization and structure of the epidermis ± microscopic and immunohistochemical analyses reveal that the epidermis of the ikka 7/7 mutants is up to ten-fold thicker than normal, while the dermis appears normal. The increased thickness of the mutant epidermis is due to hyperproliferation of cells at the basal layer (which is normally one cell thick). In addition, there appears to be a block to keratinocyte dierentiation such that instead of having a well-strati®ed epidermis the mutant mice are covered by an almost uniform layer of partially-dierentiated cells. The mutant epidermis lacks the two upper layers of keratinized and granular cells, resulting in increased adhesiveness. Transverse sections reveal that the mutant limbs and tail are actually`glued' back to the body (Hu et al., 1999) . As epidermal thickenings, such as the apical ectodermal ridge, are an important source for morphogens that control skeletal development many of the morphogenetic aberrations in ikka 7/7 mice could be secondary to a primary defect in epidermal dierentiation.
A second surprise generated by these experiments was that IKKa is not required for IKK activation by proin¯ammatory stimuli. Stimulation of ikka 7/7 embryonic ®broblasts, primary keratinocytes or liver tissue with IL-1, TNFa or endotoxin results in normal IKK activation and IkBa degradation (Hu et al., 1999; Takeda et al., 1999) . In fact, ikka 7/7 keratinocytes are hypersensitive to TNFa or IL-1, due to the replacement of less active IKKa:IKKb heterodimers with more active IKKb homodimers (Hu, unpublished results) . Despite the normal induction of IKK activity and IkB degradation, ikka 7/7 ®broblasts exhibit a substantial (approximately 50%) decrease in total NF-kB DNAbinding activity. Thus, although IKKa does not play a primary role in IKK activation it may still be involved in stimulating the translocation of NF-kB to the nucleus or enhancing NF-kB DNA-binding activity in ®broblasts, but not in hepatocytes or keratinocytes. In such a case, IKKa may function through phosphorylation of Rel/NF-kB proteins. The IKK complex in ikka 7/7 cells is of normal size and exhibits normal regulation by proin¯ammatory stimuli. As none of the currently available knockout mouse mutants that are de®cient in any of the known NF-kB subunits or Figure 4 Several models for explaining the dierent functions of IKKa and IKKb. According to model A, there is only one IKK complex, composed of IKKa, IKKb and IKKg. While the IKKb subunit is activated in response to proin¯ammatory stimuli (TNFa, IL-1, LPS) and is responsible for IkB phosphorylation, the IKKa subunit is activated in response to a yet-to-be-identi®ed developmental signal and in turn phosphorylates and modulates the activity of a key regulator of keratinocyte proliferation and dierentiation. According to model B, IKKa exerts its keratinocyte-speci®c activity as an IKKa homodimer (possibly associated with a dierent regulatory subunit). According to model C, the IKKa:IKKb heterodimer is association with IKKg has only one major function, which is the phosphorylation of IkB in response to proin¯ammatory stimuli. The activation of this complex depends on phosphorylation of IKKb and not IKKa, whose IkB kinase function can be substituted by IKKb components of the IL-1 and TNFa signaling pathways exhibit a phenotype similar to that of the ikka 7/7 mice (Gerondakis et al., 1999) , it is unlikely that the developmental and morphogenetic defects in these animals are caused by alterations in NF-kB activation. Nevertheless, during keratinocyte dierentiation the RelA subunit of NF-kB undergoes nuclear translocation (Seitz et al., 1998; Yoshioka and Hu, unpublished results) and this process is perturbed in the ikka 7/7 mutants (Takeda et al., 1999; Yoshioka and Hu, unpublished results) . At this point, however, it is not clear what signal is responsible for NF-kB activation during keratinocyte dierentiation and whether NF-kB plays an instructional role in the dierentiation process. Given the absence of any eects on epidermis development in the dierent NF-kB knockouts, it is possible that the nuclear translocation of RelA is simply another marker for keratinocyte dierentiation and that IKKa exerts its instructive function in the dierentiation process through phosphorylation of substrates other than IkBs (Figure 4) .
By contrast to the results from the IKKa knockout, little surprises were generated by the IKKb knockout. Although the loss of IKKb also results in embryonic lethality, the phenotype of ikkb 7/7 embryos is completely dierent from that of ikka 7/7 embryos at the same developmental stage, but is remarkably similar to that of rela 7/7 embryos (Li et al., 1999a,c; Tanaka et al., 1999) . IKKb-de®cient embryos die approximately at embryonic day (E) 12.5 and histopathological examination reveals that the cause of death is massive liver apoptosis (Li et al., 1999a,c; Tanaka et al., 1999) . By comparison, ikka 7/7 embryos or neonates have perfectly normal livers. A massive increase in hepatocyte apoptosis was also observed in rela 7/7 embryos, which die at E14.5 due to liver degeneration (Beg et al., 1995) . In that mice that are de®cient in both RelA and p50 also die at E12.5 (Horwitz et al., 1997) , it appears that the loss of IKKb results in a more severe decrease in NF-kB activity than the loss of RelA. RelA expression and activation is needed to protect cells from TNFa-induced apoptosis (Beg and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996) . Indeed, mice that lack both RelA and TNFa are viable and have a normal appearing liver (Doi et al., 1999) . Thus, the liver degeneration in RelA-de®cient mice is due to increased TNFa-induced hepatocyte apoptosis unopposed by NF-kB and most likely this is also the cause of death in ikkb 7/7 embryos (Li et al., 1999a) . Consistent with the liver pathology, IKKb-de®cient embryonic ®broblasts or ES cells are unable to activate IKK or NF-kB in response to either TNFa or IL-1 (Li et al., 1999c; Tanaka et al., 1999) . Thus, unlike IKKa, IKKb is absolutely required for activation of IKK and phosphorylation of IkBs.
Although these experiments provide rather de®nitive evidence for the dierent and non-overlapping functions of IKKa and IKKb, they generate a new dilemma. Does IKKa exert its developmental function as a component of the`classical' IKK complex composed of IKKa, IKKb and IKKg, or does it also function as a stand-alone kinase or a component of a completely dierent complex (Figure 4) ? The answer to this dicult question will require extensive biochemical analysis of IKK complexes in keratinocytes, the cell type in which IKKa appears to exhibit its most unique function. Once the biochemical form of IKKa involved in keratinocyte dierentiation is identi®ed, it will be possible to determine how its activity is regulated and which of its substrates plays a fate-determining role in these cells. It is also not clear whether the developmental function of IKKa is restricted to keratinocytes or whether it plays an important role in the development of other cell types. Finally, given that many signal transdcution pathways exhibit extensive crosstalk, there are likely to be several substrates, besides IkB, of the IKK complex, and future studies will no doubt yield unexpected cellular and physiogical activities for this complex. Despite the many remaining questions, it is satisfying to witness the rapid progress in understanding IKK function and regulation, given the rather recent discovery of this important protein kinase.
